Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
892.00
-1.00 (-0.11%)
At close: Jun 3, 2025

TPE:6919 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Market Capitalization
137,91194,36523,5407,528--
Upgrade
Market Cap Growth
238.59%300.87%212.69%---
Upgrade
Enterprise Value
128,36984,68522,6946,297--
Upgrade
Last Close Price
892.00615.00191.2561.13--
Upgrade
PS Ratio
3407.902123.71604.64587.23--
Upgrade
PB Ratio
14.439.736.296.47--
Upgrade
P/TBV Ratio
14.439.736.296.47--
Upgrade
EV/Sales Ratio
-1905.86582.91491.18--
Upgrade
Debt / Equity Ratio
0.000.000.010.030.062.81
Upgrade
Asset Turnover
0.010.010.020.010.030.05
Upgrade
Inventory Turnover
2.907.045.992.252.412.89
Upgrade
Quick Ratio
124.65183.4250.4823.0415.001.45
Upgrade
Current Ratio
125.22184.0250.8123.4115.261.72
Upgrade
Return on Equity (ROE)
-8.34%-8.76%-19.92%-31.64%-64.89%-528.22%
Upgrade
Return on Assets (ROA)
-6.61%-6.59%-12.68%-20.53%-30.68%-33.22%
Upgrade
Return on Capital (ROIC)
-6.71%-6.65%-12.96%-21.32%-33.58%-40.80%
Upgrade
Earnings Yield
-0.40%-0.62%-2.08%-3.80%--
Upgrade
FCF Yield
-0.36%-0.56%-1.84%-3.41%--
Upgrade
Buyback Yield / Dilution
59.56%-15.40%-5.77%-27.35%-23.49%-6.52%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.